| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | — | -19.7% |
| Cost of Revenue | $543K | — | -17.7% |
| Gross Profit | $2.0M | — | -20.2% |
| R&D Expense | $2.1M | — | +34.3% |
| SG&A Expense | $2.9M | — | +48.4% |
| Operating Income | -$3.0M | — | -196.4% |
| Pre-tax Income | -$3.0M | — | -195.7% |
| Income Tax | -$291K | — | +0.0% |
| Net Income | -$3.0M | — | -312.5% |
| EPS (Basic) | -$0.18 | — | -260.0% |
| EPS (Diluted) | -$0.18 | — | -260.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.1M | — | — |
| Inventory | $34K | +29.8% | — |
| Current Assets | $20.0M | +310.7% | — |
| Total Assets | $22.7M | +225.4% | — |
| Current Liabilities | $3.5M | -44.3% | — |
| Total Liabilities | $4.4M | -39.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | — | -579.4% |
| Investing Cash Flow | -$622K | — | -201.7% |
| Financing Cash Flow | $19.8M | — | — |
| Stockholders' Equity | $18.3M | +6359.4% | +1420.1% |